We have previously found that several different tumors that are resistant to clearance by CD8 T cells could be cleared by tumor-specific CD4 T cells, in the absence of any other T cell; and that to achieve tumor rejection, the antitumor CD4 T cells did not need to directly recognize the tumor cells, but rather partnered with a local stromal cell type (1). The gene discussed is CD4; the disease is neoplasm.